This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n13http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48329175
rdf:type
wikibase:Item
schema:description
מאמר מדעי ১০ নভেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikel ilmiah 2017年學術文章 наукова стаття, опублікована в листопаді 2017 artykuł naukowy wetenschappelijk artikel wissenschaftlicher Artikel artikull shkencor 2017年學術文章 article científic научни чланак научная статья tieteellinen artikkeli article scientific 2017年学术文章 articol științific scienca artikolo artículu científicu სამეცნიერო სტატია 2017年の論文 tudományos cikk artigo científico scientific article published on 10 November 2017 videnskabelig artikel artículo científico publicado en 2017 2017年学术文章 2017年学术文章 naučni članak artikulong pang-agham 2017年学术文章 vitskapeleg artikkel 2017年學術文章 บทความทางวิทยาศาสตร์ 2017 թվականի նոյեմբերի 10-ին հրատարակված գիտական հոդված article scientifique мақолаи илмӣ vědecký článek 2017年学术文章 επιστημονικό άρθρο bài báo khoa học teaduslik artikkel artigo científico scientific article published on 10 November 2017 مقالة علمية نشرت في 10 نوفمبر 2017 articolo scientifico vitenskapelig artikkel vedecký článok 2017년 논문 научна статия 2017年學術文章 2017年學術文章 bilimsel makale 2017年学术文章 научни чланак vetenskaplig artikel 2017 nî lūn-bûn artigo científico scientific article published on 10 November 2017
p:P577
wds:Q48329175-678A6490-AB64-49CF-80E3-C004C6E29DEA
wdt:P577
2017-11-10T00:00:00Z
p:P2888
wds:Q48329175-C63557A0-75EE-47DA-A0D7-AF4F6F9586E6
wdt:P2888
n11:s00259-017-3870-6
p:P2860
wds:Q48329175-3E0CB947-B3D0-4FCD-88EA-CC75289E60B4 wds:Q48329175-43AE0161-C88F-4F88-A608-492A13213674 wds:Q48329175-276A386F-3187-48D0-B3B9-9A85F9B47452 wds:Q48329175-31F27368-FBFE-4A31-94FF-C03D6880968F wds:Q48329175-36A49BA4-EAE4-436E-9A53-1484AC5DBD04 wds:Q48329175-1C98595C-7164-462B-959D-66441B5091EC wds:Q48329175-049D458E-B2D5-4549-A12E-93DBEE9DA2F6 wds:Q48329175-AEFE0403-F627-48A0-8B47-E6EF57F1AE64 wds:Q48329175-8FE92DB5-53AF-45FD-B93A-9746C73B3375 wds:Q48329175-6F60CA1D-050D-4354-BD9C-00E9872C0D75 wds:Q48329175-742F484B-2684-4BB1-BB5D-74614D683F50 wds:Q48329175-554E2D65-B8CC-4EFA-9A28-42B4FF8E3A46 wds:Q48329175-5A434A2B-4948-431E-AA28-F4E28DC62FC5 wds:Q48329175-FE014778-7606-4EC6-9141-E02192863F3E wds:Q48329175-EBE4E1AD-8F9C-46D8-B4E8-2C3871E279D6 wds:Q48329175-ECA5E3CC-43EA-4BFE-9540-3BFB6759FA99 wds:Q48329175-FB545FBF-87CA-4C79-B75C-309F0595024C wds:Q48329175-C6C88966-04B5-4110-923C-6E39193F4FBC wds:Q48329175-DFC24B0E-8D18-4AE8-A69F-1A8F7229667D
wdt:P2860
wd:Q28265610 wd:Q39000327 wd:Q48190235 wd:Q38748974 wd:Q33837310 wd:Q36132702 wd:Q39227781 wd:Q36498459 wd:Q29614803 wd:Q48525547 wd:Q43164814 wd:Q38866250 wd:Q38389152 wd:Q28069873 wd:Q38884560 wd:Q37139226 wd:Q60652342 wd:Q28299244 wd:Q29620070
p:P2093
wds:Q48329175-7F769AEE-7095-4E06-82B6-D55BC790B97C
wdt:P2093
Uwe Haberkorn
rdfs:label
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
skos:prefLabel
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
schema:name
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
p:P50
wds:Q48329175-61E55547-A673-4FEA-80D0-50935369E53E wds:Q48329175-A0C8D532-49CE-46A6-9053-C558996B475A wds:Q48329175-A95F0056-22AF-4044-AFEC-73C2033BE1D6 wds:Q48329175-B0B50B9E-029D-4BFA-BE18-425F0B73C58B wds:Q48329175-09D6CE5A-8933-44C5-AFE8-275943C61A01 wds:Q48329175-239ED6C7-E289-41EA-A427-A356C089DA32
wdt:P50
wd:Q90501222 wd:Q43115581 wd:Q47668389 wd:Q89707783 wd:Q87871294 wd:Q37610900
p:P1476
wds:Q48329175-DA7AED58-214F-4037-A8E9-9CC26FBFAC06
wdt:P1476
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
p:P304
wds:Q48329175-615149A0-E526-4E67-97C8-C27AC18C334F
wdt:P304
376-383
p:P31
wds:Q48329175-953F40C3-5FEC-4BCB-A448-CCD0937AD446
wdt:P31
wd:Q13442814
p:P921
wds:Q48329175-3605BC7D-DC2B-4258-9EDA-1F377C1652F5
wdt:P921
wd:Q18975855
p:P698
wds:Q48329175-43351335-482B-45B3-934D-C25BC2CFDE78
wdtn:P698
n8:29124281
wdt:P698
29124281
p:P1433
wds:Q48329175-0715F5DB-7BE0-484D-B4B7-EC8C766BFB99
wdt:P1433
wd:Q15708890
p:P433
wds:Q48329175-73EE8197-88C1-4525-90E7-1EB23E845E30
p:P478
wds:Q48329175-C2CA4D68-EE4B-4A53-A6F3-5A335EFDA29C
wdt:P433
3
wdt:P478
45
p:P1104
wds:Q48329175-ED1DB2B3-FABA-4887-9A43-1E4E9F4106B0
wdt:P1104
8
p:P356
wds:Q48329175-4097D239-1F54-4A49-8288-E2C43251A174
wdtn:P356
n13:S00259-017-3870-6
wdt:P356
10.1007/S00259-017-3870-6